The role of cofactors in sex steroid action

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 21, Issue 3, 2007, Pages 403-414

  Trapman, Jan ^a   Dubbink, Hendrikus Jan ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

androgen insensitivity; androgen receptor; cofactor; transcription

Indexed keywords

ANDROGEN RECEPTOR; CELL RECEPTOR; HISTONE; SEX HORMONE; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

ANDROGEN INSENSITIVITY SYNDROME; CHROMATIN STRUCTURE; COMPLEX FORMATION; ENZYME ACTIVITY; GENE TARGETING; HORMONE ACTION; HUMAN; MALE; PHENOTYPE; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SEXUAL DEVELOPMENT; SIGNAL TRANSDUCTION;

ADULT; ANDROGEN-INSENSITIVITY SYNDROME; ANIMALS; BINDING SITES; DIMERIZATION; FEMALE; GENE EXPRESSION REGULATION; GONADAL STEROID HORMONES; HUMANS; LIGANDS; MALE; RECEPTORS, ANDROGEN; RECEPTORS, STEROID; RESPONSE ELEMENTS; SEXUAL DEVELOPMENT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 34548590196     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2007.07.002     Document Type: Review

References (48)

1. Brinkmann A.O., Blok L.J., De Ruiter P.E., et al. Mechanisms of androgen receptor activation and function. The Journal of Steroid Biochemistry and Molecular Biology 69 (1999) 307-313
2. McKenna N.J., and O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 (2002) 465-474
3. Germain P., Staels B., Dacquet C., et al. Overview of nomenclature of nuclear receptors. Pharmacological Reviews 58 (2006) 685-704
4. McEwan I.J., Lavery D., Fischer K., et al. Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors. Nuclear Receptor Signaling 5 (2007) e001
5. Greschik H., and Moras D. Structure-activity relationship of nuclear receptor-ligand interactions. Current Topics in Medicinal Chemistry 3 (2003) 1573-1599
6. Quigley C.A., De Bellis A., Marschke K.B., et al. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Reviews 16 (1995) 271-321
7. Brinkmann A.O. Molecular basis of androgen insensitivity. Molecular and Cellular Endocrinology 179 (2001) 105-109
8. Shaffer P.L., Jivan A., Dollins D.E., et al. Structural basis of androgen receptor binding to selective androgen response elements. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 4758-4763
9. Matias P.M., Donner P., Coelho R., et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor, implications for pathogenic mutations. The Journal of Biological Chemistry 275 (2000) 26164-26171
10. Sack J.S., Kish K.F., Wang C., et al. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural antagonist dihydrotestosterone. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 4904-4909
11. Estebanez-Perpina, Moore J.M.R., Mar E., et al. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor. The Journal of Biological Chemistry 280 (2005) 8060-8068
12. Doesburg P., Kuil C.W., Berrevoets C.A., et al. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 36 (1997) 1052-1064
13. He B., Kemppainen J.A., and Wilson E.M. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. The Journal of Biological Chemistry 275 (2000) 22986-22994
14. Schaufele F., Carbonell X., Guerbadot, et al. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxyl interactions. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 9802-9807
15. Klokk T.I., Kurys P., Elbi C., et al. Ligand-specific dynamics of the androgen receptor at its response element. Molecular and Cellular Biology 27 (2007) 1823-1843
16. Van Royen M.E., Cunha S.M., Brink M.C., et al. Compartmentalization of androgen receptor protein-protein interactions in living cells. The Journal of Cell Biology 177 (2007) 63-72
17. He B., Gampe R.T., Kole A.J., et al. Structural basis for androgen receptor interdomain interaction and coactivator interactions suggests a transition in nuclear activation function dominance. Molecular Cell 16 (2004) 425-438
18. Hur E., Pfaff S.J., Payne E.S., et al. Recognition and accommodation at the androgen receptor coactivator binding interface. PloS Biolology 2 (2004) e274
19. Li J, Zhang D, Fu J, et al. Structural and functional analysis of androgen receptor in chromatin. Molecular Endocrinology (in press), doi:10.1210/me.2006-0221 [Epub ahead of print].
20. Zhou Z.X., Lane M.V., Kemppainen J.A., et al. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Molecular Endocrinology 9 (1995) 208-218
21. Dubbink H.J., Hersmus R., Verma C.S., et al. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Molecular Endocrinology 18 (2004) 2132-2150
22. He B., Gampe R.T., Hnat A.T., et al. Probing the functional link between androgen receptor coactivator and ligand binding sites in prostate cancer and androgen insensitivity. The Journal of Biological Chemistry 281 (2006) 6648-6663
23. Rosenfeld M.G., Lunyak V.V., and Glass C.K. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes & Development 20 (2006) 1405-1428
24. Kouzarides T. Chromatin modifications and their function. Cell 128 (2007) 693-705
25. Li B., Carey M., and Workman J.L. The role of chromatin during transcription. Cell 128 (2007) 707-719
26. Hall J.M., and McDonnell D.P. Coregulators in nuclear estrogen receptor action. Molecular Interventions 6 (2005) 343-357
27. Chen J., Kinyamu H.K., and Archer T.K. Changes in attitude, changes in latitude: nuclear receptors remodelling chromatin to regulate transcription. Molecular Endocrinology 20 (2006) 1-13
28. Kornberg R.D. Mediator and the mechanism of transcriptional activation. Trends in Biochemical Sciences 30 (2005) 235-239
29. Malik S., and Roeder R.G. Dynamic regulation of pol II transcription by the mammalian Mediator complex. Trends in Biochemical Sciences 30 (2005) 256-263
30. Belakavadi M., and Fondell J.D. Role of the mediator complex in nuclear hormone receptor signaling. Reviews of Physiology Biochemistry and Pharmacology 156 (2006) 23-43
31. Alen P., Claessens F., Verhoeven G., et al. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Molecular and Cellular Biology 19 (1999) 6085-6097
32. Dubbink H.J., Hersmus R., Pike A.C.W., et al. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Molecular Endocrinology 20 (2006) 1742-1755
33. He B., Minges J.T., Lee L.W., et al. The FXXLF motif mediates androgen receptor-specific interactions with coregulators. The Journal of Biological Chemistry 277 (2002) 10226-10235
34. Van de Wijngaart D.J., Van Royen M.E., Hersmus R., et al. Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain. The Journal of Biological Chemistry 281 (2006) 19407-19416
35. Bai S., He B., and Wilson E.M. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Molecular and Cellular Biology 25 (2005) 1238-1257
36. Heinlein C.A., and Chang C. Androgen receptor (AR) coregulators: an overview. Endocrine Reviews 23 (2002) 175-200
37. Link K.A., Burd C.J., Williams E., et al. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Molecular and Cellular Biology 25 (2005) 2200-2215
38. Domanskyi A., Virtanen K.T., Palvimo J.J., et al. Biochemical characterization of androgen receptor-interacting protein 4. Biochemical Journal 393 (2006) 789-795
39. Wang Q., Sharma D., Ren Y., et al. A coregulatory role for the TRAP-Mediator complex in androgen receptor-mediated gene expression. The Journal of Biological Chemistry 277 (2002) 42852-42858
40. Coulthart V.H., Matsuda S., and Heery D.M. An extended LXXLL motif sequence determines the nuclear receptor binding specificity of TRAP220. The Journal of Biological Chemistry 278 (2003) 10942-10951
41. McNally J.G., Mueller W.G., Walker D., et al. The glucocorticoid receptor: rapid exchange with regulatory sites. Science 287 (2000) 1262-1265
42. Farla P., Hersmus R., Geverts B., et al. The androgen receptor ligand-binding domain stabilizes DNA binding in living cells. Journal of Structural Biology 147 (2004) 50-61
43. Becker M., Baumann C., John S., et al. Dynamic behavior of transcription factors on a natural promoter in living cells. EMBO Reports 3 (2002) 1188-1194
44. Metivier R., Reid G., and Gannon F. Transcription in four dimensions: Nuclear receptor-directed initiation of gene expression. EMBO Reports 7 (2006) 1439-1446
45. Adachi M., Takayanagi R., Tomura A., et al. Androgen-insensitivity syndrome as a possible coactivator disease. The New England Journal of Medicine 343 (2000) 856-862
46. Petrij F., Giles R.H., Dauwerse H.G., et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376 (1995) 348-351
47. Roberts C.W.M., and Orkin S.H. The SWI/SNF complex - chromatin and cancer. Nature Reviews. Cancer 4 (2004) 133-142
48. Anzick S.L., Kononen J., Walker R.L., et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277 (1997) 965-968